Waters launches XBridge Premier GTx BEH SEC columns for gene therapy applications

FHS
August 24, 2023
10:21 am

Waters Corporation introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

Extreme heat alert: Understanding the impact of heatwaves on public health

According to a joint heat-health warning issued by the UK Health Security Agency (UKHSA) and Met Office, parts of the UK are forecast to experience

July 19, 2024

Evotec ends gene therapy business, shuts down facility in Austria

Evotec has provided further updates to its “priority reset” as the CRDMO exits the gene therapy space and closes a site in Austria which would

May 23, 2024

Kids With MS May Have Better Outcomes When Started on High-Efficacy Treatment Early

Starting high-efficacy monoclonal antibody therapy during childhood reduced long-term disability in pediatric-onset multiple sclerosis (MS), registry data suggested. Among 282 patients with pediatric-onset MS, 39%

September 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.